Donor lymphocyte infusion (DLI) post haploidentical stem cell transplantation (Haplo) with post-transplant cyclophosphamide (PTCy): crossing the human leukocyte antigen (HLA) barrier

Arnon Nagler, Panagiotis Tsirigotis*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalBone Marrow Transplantation
DOIs
StateAccepted/In press - 2022

Cite this